Nuclear medicine vendor ADAC Laboratories (Hall B, #6711) is promising a new product announcement for the meeting but is planning to keep the news to itself until the show. One new product the Milpitas, CA-based company is talking about is WebView, a
Nuclear medicine vendor ADAC Laboratories (Hall B, #6711) is promising a new product announcement for the meeting but is planning to keep the news to itself until the show. One new product the Milpitas, CA-based company is talking about is WebView, a work-in-progress workstation that enables physicians to interpret and process images in their departments, homes, or offices.
General-purpose and specialized SPECT and cardiac displays have been built into WebView. In addition to nuclear medicine studies, WebView supports multimodality images via the DICOM 3.0 standard. The software runs on Windows NT and Windows 95 operating systems.
ADAC will also discuss MCD/AC, the company's high-energy Molecular Coincidence Detection upgrade package with attenuation correction capabilities. MCD/AC uses an external cesium-137 radioactive source to create an attenuation map of tissue densities in the body, and this map is used to compensate for artifacts created by tissue, bone, and other obstructions (SCAN 6/25/97).
MCD/AC improves the visualization of organs and structures deep in the body and could help extend coincidence detection from oncology applications into cardiology uses. MCD/AC received 510(k) clearance in October.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
June 19th 2025Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.